ESR1 and papillary serous cystadenocarcinoma: The analysis conducted by Xiao et al. detected the expression of ER in only 7.7% (2/26) of ovarian CCC and 91.8% (22/24) of papillary serous carcinoma cases, while PR expression was not significantly different between them.